A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan. [electronic resource]
Producer: 20141021Description: 479-86 p. digitalISSN:- 1432-0843
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Cancer Vaccines -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Diarrhea -- chemically induced
- Drug Administration Schedule
- Female
- Gastrins -- administration & dosage
- Humans
- Infusions, Intravenous
- Injections, Intramuscular
- Irinotecan
- Male
- Middle Aged
- Nausea -- chemically induced
- Neutropenia -- chemically induced
- Treatment Outcome
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.